NEOPROBE CORP
10-K405/A, EX-23.1, 2000-08-07
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: NEOPROBE CORP, 10-K405/A, 2000-08-07
Next: NEOPROBE CORP, 10-K405/A, EX-23.2, 2000-08-07



<PAGE>   1
Exhibit 23.1



                       CONSENT OF INDEPENDENT ACCOUNTANTS


We consent to the incorporation by reference in the Registration Statements of
Neoprobe Corporation and Subsidiaries listed below of our report dated February
20, 1998, on our audit of the consolidated statements of operations,
stockholders' equity, and cash flows of Neoprobe Corporation and Subsidiaries
for the year ended December 31, 1997, which report is included in this Annual
Report on the Form 10-K/A.

Form S-3 File No. 33-72700
Form S-3 File No. 33-73622
Form SB-2 File No. 33-86000
Form S-3 File No. 33-93438
Form S-3 File No. 33-93858
Form S-3 File No. 333-15989
Form S-8 File No. 33-70074
Form S-8 File No. 33-81410
Form S-8 File No. 333-05143



                                            /s/ PricewaterhouseCoopers LLP
                                            PricewaterhouseCoopers LLP


Columbus, Ohio
August 3, 2000



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission